ABC-transporter CFTR folds with high fidelity through a modular, stepwise pathway

[1]  P. van der Sluijs,et al.  Structure basis of CFTR folding, function and pharmacology. , 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[2]  R. Allikmets,et al.  The human ATP‐binding cassette (ABC) transporter superfamily , 2022, Human mutation.

[3]  W. Balch,et al.  Spatial covariance analysis reveals the residue-by-residue thermodynamic contribution of variation to the CFTR fold , 2022, Communications Biology.

[4]  Jue Chen,et al.  Mechanism of CFTR correction by type I folding correctors , 2021, Cell.

[5]  A. J. Higgins,et al.  Author Correction: Cycloalkane-modified amphiphilic polymers provide direct extraction of membrane proteins for CryoEM analysis , 2021, Communications biology.

[6]  Lisa D. Cabrita,et al.  Nascent chains can form co-translational folding intermediates that promote post-translational folding outcomes in a disease-causing protein , 2021, Nature Communications.

[7]  J. Mornon,et al.  Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR , 2021, Cellular and Molecular Life Sciences.

[8]  E. Pardon,et al.  A topological switch in CFTR modulates channel activity and sensitivity to unfolding , 2021, Nature Chemical Biology.

[9]  J. Bednenko,et al.  Membrane protein production and formulation for drug discovery. , 2021, Trends in pharmacological sciences.

[10]  H. Senderowitz,et al.  The CFTR P67L variant reveals a key role for N-terminal lasso helices in channel folding, maturation, and pharmacologic rescue , 2021, The Journal of biological chemistry.

[11]  P. van der Sluijs,et al.  Co-translational folding of the first transmembrane domain of ABC-transporter CFTR is supported by assembly with the first cytosolic domain. , 2021, Journal of molecular biology.

[12]  P. van der Sluijs,et al.  Co-translational folding of the first transmembrane domain of ABC-transporter CFTR is supported by assembly with the first cytosolic domain , 2020, bioRxiv.

[13]  C. Bear,et al.  Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator , 2020, European Respiratory Journal.

[14]  P. van der Sluijs,et al.  Clinical and molecular characterization of the R751L-CFTR mutation , 2020, American journal of physiology. Lung cellular and molecular physiology.

[15]  G. Lukács,et al.  Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination , 2020, JCI insight.

[16]  W. Skach,et al.  CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates , 2020, Nature Communications.

[17]  J. Hartman,et al.  Slowing ribosome velocity restores folding and function of mutant CFTR. , 2019, The Journal of clinical investigation.

[18]  X. Zou,et al.  Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770 , 2019, The Journal of general physiology.

[19]  A. O. Falcão,et al.  Folding Status Is Determinant over Traffic-Competence in Defining CFTR Interactors in the Endoplasmic Reticulum , 2019, Cells.

[20]  I. Braakman,et al.  Analysis of Protein Folding, Transport, and Degradation in Living Cells by Radioactive Pulse Chase. , 2019, Journal of visualized experiments : JoVE.

[21]  P. van der Sluijs,et al.  Folding–function relationship of the most common cystic fibrosis–causing CFTR conductance mutants , 2019, Life Science Alliance.

[22]  Jue Chen,et al.  Molecular structure of the ATP-bound, phosphorylated human CFTR , 2018, Proceedings of the National Academy of Sciences.

[23]  F. van Goor,et al.  VX‐445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles , 2018, The New England journal of medicine.

[24]  Bernd Bukau,et al.  Cotranslational assembly of protein complexes in eukaryotes revealed by ribosome profiling , 2018, Nature.

[25]  J. Mornon,et al.  Combining theoretical and experimental data to decipher CFTR 3D structures and functions , 2018, Cellular and Molecular Life Sciences.

[26]  Zhengrong Yang,et al.  Direct Binding of the Corrector VX-809 to Human CFTR NBD1: Evidence of an Allosteric Coupling between the Binding Site and the NBD1:CL4 Interface , 2017, Molecular Pharmacology.

[27]  D. Veprintsev,et al.  High-throughput mutagenesis using a two-fragment PCR approach , 2017, Scientific Reports.

[28]  D. Clarke,et al.  Corrector VX‐809 promotes interactions between cytoplasmic loop one and the first nucleotide‐binding domain of CFTR , 2017, Biochemical pharmacology.

[29]  J. Riordan,et al.  Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations , 2017, The Journal of Biological Chemistry.

[30]  D. Gadsby,et al.  Molecular Structure of the Human CFTR Ion Channel , 2017, Cell.

[31]  D. Hebert,et al.  Analysis of Disulfide Bond Formation , 1996, Current protocols in protein science.

[32]  Jue Chen,et al.  Atomic Structure of the Cystic Fibrosis Transmembrane Conductance Regulator , 2016, Cell.

[33]  P. Barth,et al.  A topological and conformational stability alphabet for multipass membrane proteins. , 2016, Nature chemical biology.

[34]  C. Farinha,et al.  From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking , 2016, Cellular and Molecular Life Sciences.

[35]  G. Lukács,et al.  Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop* , 2015, The Journal of Biological Chemistry.

[36]  Salvador Martínez-Bartolomé,et al.  ΔF508 CFTR interactome remodeling promotes rescue of Cystic Fibrosis , 2015, Nature.

[37]  Alexey Drozdetskiy,et al.  JPred4: a protein secondary structure prediction server , 2015, Nucleic Acids Res..

[38]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[39]  F. van Goor,et al.  Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[40]  Hong Yu Ren,et al.  VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1 , 2013, Molecular biology of the cell.

[41]  George P Patrinos,et al.  Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene , 2013, Nature Genetics.

[42]  G. von Heijne,et al.  Cotranslational folding of membrane proteins probed by arrest-peptide–mediated force measurements , 2013, Proceedings of the National Academy of Sciences.

[43]  J. Forman-Kay,et al.  Structural changes of CFTR R region upon phosphorylation: a plastic platform for intramolecular and intermolecular interactions , 2013, The FEBS journal.

[44]  Soo-Jung Kim,et al.  Mechanisms of CFTR Folding at the Endoplasmic Reticulum , 2012, Front. Pharmacol..

[45]  G. Fields,et al.  Introduction to Peptide Synthesis , 2012, Current protocols in protein science.

[46]  J. Yates,et al.  A Chaperone Trap Contributes to the Onset of Cystic Fibrosis , 2012, PloS one.

[47]  Philip J. Thomas,et al.  Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences , 2012, Cell.

[48]  K. Du,et al.  Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function , 2012, Cell.

[49]  Qiuyan Wang,et al.  A ubiquitin ligase-associated chaperone holdase maintains polypeptides in soluble states for proteasome degradation. , 2011, Molecular cell.

[50]  D. G. Gibson,et al.  Enzymatic Assembly of Overlapping DNA Fragments , 2011, Methods in Enzymology.

[51]  W. Skach,et al.  Ligand-driven vectorial folding of ribosome-bound human CFTR NBD1. , 2011, Molecular cell.

[52]  G. Lukács,et al.  CFTR Folding Consortium: methods available for studies of CFTR folding and correction. , 2011, Methods in molecular biology.

[53]  Philip J. Thomas,et al.  The Primary Folding Defect and Rescue of ΔF508 CFTR Emerge during Translation of the Mutant Domain , 2010, PloS one.

[54]  Pradeep Kota,et al.  Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR. , 2010, Journal of molecular biology.

[55]  H. Senderowitz,et al.  The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis* , 2010, The Journal of Biological Chemistry.

[56]  John F Hunt,et al.  Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant. , 2010, Protein engineering, design & selection : PEDS.

[57]  Xiaodong Wang,et al.  Interplay between ER Exit Code and Domain Conformation in CFTR Misprocessing and Rescue , 2010, Molecular biology of the cell.

[58]  D. Cyr,et al.  Mechanisms for rescue of correctable folding defects in CFTRDelta F508. , 2009, Molecular biology of the cell.

[59]  Isabelle Callebaut,et al.  Molecular models of the open and closed states of the whole human CFTR protein , 2009, Cellular and Molecular Life Sciences.

[60]  P. Negulescu,et al.  Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 , 2009, Proceedings of the National Academy of Sciences.

[61]  W. Skach.  Cellular mechanisms of membrane protein folding , 2009, Nature Structural &Molecular Biology.

[62]  G. von Heijne,et al.  Membrane-integration characteristics of two ABC transporters, CFTR and P-glycoprotein. , 2009, Journal of molecular biology.

[63]  Kai Du,et al.  Cooperative assembly and misfolding of CFTR domains in vivo. , 2009, Molecular biology of the cell.

[64]  Vasilis Vasiliou,et al.  Human ATP-binding cassette (ABC) transporter family , 2009, Human Genomics.

[65]  A. Rath,et al.  Detergent binding explains anomalous SDS-PAGE migration of membrane proteins , 2009, Proceedings of the National Academy of Sciences.

[66]  Nikolay V. Dokholyan,et al.  Multiple Membrane-Cytoplasmic Domain Contacts in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mediate Regulation of Channel Gating* , 2008, Journal of Biological Chemistry.

[67]  V. Vasiliou.  Welcome back to Human Genomics. , 2008, Human genomics.

[68]  Adrian W. R. Serohijos,et al.  Phenylalanine-508 mediates a cytoplasmic–membrane domain contact in the CFTR 3D structure crucial to assembly and channel function , 2008, Proceedings of the National Academy of Sciences.

[69]  J. Forman-Kay,et al.  CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices , 2007, Nature Structural &Molecular Biology.

[70]  Andrei Aleksandrov,et al.  Domain interdependence in the biosynthetic assembly of CFTR. , 2007, Journal of molecular biology.

[71]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[72]  W. Skach,et al.  Molecular mechanisms of aquaporin biogenesis by the endoplasmic reticulum Sec61 translocon. , 2006, Biochimica et biophysica acta.

[73]  I. Braakman,et al.  Folding of CFTR is predominantly cotranslational. , 2005, Molecular cell.

[74]  L. David,et al.  Reticulocyte lysate as a model system to study endoplasmic reticulum membrane protein degradation. , 2005, Methods in molecular biology.

[75]  Kai Du,et al.  The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR , 2005, Nature Structural &Molecular Biology.

[76]  Chad A Brautigam,et al.  Side chain and backbone contributions of Phe508 to CFTR folding , 2005, Nature Structural &Molecular Biology.

[77]  W. Skach,et al.  Biogenesis of CFTR and other Polytopic Membrane Proteins: New Rolesfor the Ribosome-Translocon Complex , 2004, The Journal of Membrane Biology.

[78]  J. Riordan,et al.  COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code , 2004, The Journal of cell biology.

[79]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[80]  G. Lukács,et al.  Antibodies for CFTR studies. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[81]  M. Tzetis,et al.  Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A→G, 2751+2T→A, 296+1G→C, 1717–9T→C-D565G) and one nonsense mutation (E822X) in the CFTR gene , 2001, Human Genetics.

[82]  M. Tzetis,et al.  CFTR gene mutations – including three novel nucleotide substitutions – and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease , 2001, Human Genetics.

[83]  A. Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.

[84]  F. Hartl,et al.  An unstable transmembrane segment in the cystic fibrosis transmembrane conductance regulator , 1999, The EMBO journal.

[85]  J. Blalock,et al.  CFTR chloride channel regulation by an interdomain interaction. , 1999, Science.

[86]  J. Riordan,et al.  Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome , 1998, The EMBO journal.

[87]  M. Tzetis,et al.  Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligozoospermia. , 1998, Molecular human reproduction.

[88]  W. Skach,et al.  Co- and Posttranslational Translocation Mechanisms Direct Cystic Fibrosis Transmembrane Conductance Regulator N Terminus Transmembrane Assembly* , 1998, The Journal of Biological Chemistry.

[89]  E. Strickland,et al.  Localization and Suppression of a Kinetic Defect in Cystic Fibrosis Transmembrane Conductance Regulator Folding* , 1997, The Journal of Biological Chemistry.

[90]  P. Thomas,et al.  Alteration of the Cystic Fibrosis Transmembrane Conductance Regulator Folding Pathway , 1996, The Journal of Biological Chemistry.

[91]  M. Chen,et al.  Membrane insertion, processing, and topology of cystic fibrosis transmembrane conductance regulator (CFTR) in microsomal membranes. , 1996, Molecular membrane biology.

[92]  S. High,et al.  The translocation, folding, assembly and redox-dependent degradation of secretory and membrane proteins in semi-permeabilized mammalian cells. , 1995, The Biochemical journal.

[93]  A Helenius,et al.  Folding of influenza hemagglutinin in the endoplasmic reticulum , 1991, The Journal of cell biology.

[94]  M. Welsh,et al.  Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. , 1991, Science.

[95]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[96]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.